Rating History for Crescent Biopharma Inc (CBIO) by H.C. Wainwright
| Date | Analyst | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|
| 6/1/2026 | Mitchell S. Kapoor | Downgrade | Neutral (Buy) |
N/A (N/A) |
20.65 (17.48) |
-15.35% | Details |
![]() |
|||||||
![]() |
|||||||


